These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4405540)

  • 1. Structure-activity relationship for antiarrhytmic actions of -receptor blocking drugs.
    Somani P; Laddu AR
    Eur J Pharmacol; 1971 May; 14(3):209-16. PubMed ID: 4405540
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic activity of 1-(di-2,6-xylylmethoxy)-3-(isopropylamino) propanol-2-hydrochloride (BS-7977-d) in the dog heart lung preparation.
    Laddu R
    Eur J Pharmacol; 1970 Feb; 9(2):129-35. PubMed ID: 4392344
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
    Cheymol G; Honnorat C; Schmitt H
    Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism of cardiac arrhythmias by dl-1-(2-acetyl-4-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane (M & B 17,803A), a new beta adrenoreceptor blocking agent.
    Laddu AR
    Jpn Heart J; 1974 Jan; 15(1):61-71. PubMed ID: 4151909
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemodynamic effects of oxprenolol and practolol in dogs under halothane anaesthesia.
    Strong AJ; Macnicol MF; Davie IT; Scott DB
    Br J Anaesth; 1971 Jan; 43(1):25-32. PubMed ID: 4396678
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology of practolol, a cardioselective beta adrenergic blocking drug.
    Fitzgerald JD
    Acta Cardiol; 1972; Suppl 16():1-18. PubMed ID: 4405742
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-receptor blocking and cardiodepressant actions of 2-nitrilophenoxypropanolamines.
    Mylecharane EJ; Raper C
    Eur J Pharmacol; 1971 Sep; 16(1):14-20. PubMed ID: 4400509
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 15. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic effects of beta-receptor blocking drugs during nitrous oxide-halothane anaesthesia.
    Stephen GW; Davie IT; Scott DB
    Br J Anaesth; 1971 Apr; 43(4):320-5. PubMed ID: 4396861
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemodynamic studies on the beta receptor blockader Kö 592 under rest and under exertion].
    Deibert K; Steim H; Heinrich K; Siller K
    Med Klin; 1972 Jun; 67(24):845-9. PubMed ID: 4403610
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB; Kennedy I; Levy GP; Marshall RJ
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.